Crossmark

Efficacy and safety of fezolinetant and its different doses in the treatment of vasomotor symptoms in menopausal women: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s43043-025-00231-y

Published Online: 2025-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ismail, Rahma Abdelaziz https://orcid.org/0000-0002-7722-6863
Shaheen, Rahma Sameh https://orcid.org/0000-0001-5200-6138
Afifi, Eslam https://orcid.org/0009-0000-6667-0021
Sayad, Reem https://orcid.org/0000-0002-4378-2714
Sherif, Leenah N. https://orcid.org/0000-0001-8836-2724
Aranda, Mohamed Ibrahim https://orcid.org/0009-0005-4201-0826
Al Gohary, Rawda A. https://orcid.org/0000-0003-1100-9089
Elsaeidy, Ahmed Saad https://orcid.org/0000-0002-1643-9750
License Information

Text and Data Mining valid from 2025-06-02

Version of Record valid from 2025-06-02
More Information

Article History

Received: 14 December 2024

Accepted: 19 May 2025

First Online: 2 June 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.